Remicade can produce noticeable symptom improvement within one to two weeks of the first infusion, though full clinical remission typically takes around eight weeks. In cases of acute severe colitis, a response can appear within the first seven days. The speed varies significantly depending on how inflamed your colon is and how well your body retains the drug.
The First Few Weeks
Remicade is given as an IV infusion, and the initial loading phase follows a set schedule: infusions at week 0, week 2, and week 6. After that, maintenance infusions continue every eight weeks. Most people notice their first improvements somewhere between the first and second infusion.
If you’re coming off steroids that weren’t controlling your symptoms, there’s a reasonable chance of early relief. In one prospective study, about half of patients who hadn’t responded to steroids experienced a clinical response within two weeks of their first Remicade infusion. Early signs that it’s working include less frequent bowel movements, less blood in your stool, reduced urgency, and less abdominal cramping. These changes can be subtle at first, so tracking your symptoms daily gives you a clearer picture of whether things are trending in the right direction.
When Full Remission Happens
While early symptom relief is encouraging, full remission, meaning your symptoms resolve and the inflammation in your colon begins to heal, generally takes longer. The expected window for clinical remission is around eight weeks, which aligns with the end of the three-dose induction phase. Actual healing of the colon lining takes longer still, often six months or more before endoscopy shows meaningful mucosal repair.
This distinction matters. Feeling better doesn’t always mean the inflammation is fully under control. Your gastroenterologist will likely check inflammatory markers in your blood and stool, and eventually perform a follow-up colonoscopy, to confirm that the drug is doing its job beneath the surface.
Why Some People Respond Faster Than Others
Your body’s inflammatory burden plays a major role in how quickly Remicade works. The drug targets a specific inflammatory protein called TNF-alpha, triggering the death of immune cells that are driving the inflammation. But several factors can interfere with how much of the drug actually stays in your system long enough to work.
When ulcerative colitis is severe, the damaged colon lining essentially leaks the drug into the intestinal space, where it’s lost in stool. Patients with high levels of inflammation (reflected by elevated CRP in blood work) and low albumin levels tend to clear the drug faster, resulting in lower drug concentrations during the critical induction period. One study found that high baseline CRP (above 50 mg/L) and low albumin (below 35 g/L) were independently associated with lower Remicade levels over the first six weeks, which in turn predicted a weaker response.
The severity of your colon’s visible damage also matters. In a retrospective study of 113 patients with acute severe UC, about one-third of those with deep ulcers or spontaneous bleeding at baseline eventually needed surgery within 12 months, compared to just 6% of those without those severe findings. More severe disease at the start doesn’t mean Remicade won’t work, but it does mean your doctor may need to adjust dosing to compensate for faster drug clearance.
What Happens If It Doesn’t Work
There’s no universal definition of treatment failure, but a commonly used benchmark is the absence of meaningful clinical response within 14 weeks of starting treatment. If you’ve completed the full induction schedule and your symptoms haven’t improved, this is considered primary non-response.
Before concluding that Remicade has failed, your doctor will want to rule out other explanations for persistent symptoms. Infections, irritable bowel overlap, bacterial overgrowth, and bile acid malabsorption can all mimic a flare. Blood tests, stool markers like fecal calprotectin, and sometimes repeat endoscopy help clarify whether active inflammation is truly the problem.
Drug level testing is also a key step. If your Remicade levels are too low, the issue may be that your body is clearing the drug too quickly or has developed antibodies against it, rather than the drug being fundamentally ineffective. In those cases, dose adjustments or shorter intervals between infusions can sometimes rescue the response. If antibodies are present and drug levels are undetectable, switching to a different biologic is the usual next step.
Loss of Response Over Time
Some people respond well initially but then gradually lose that response months or years into treatment. This is distinct from primary non-response and is called secondary loss of response. Symptoms creep back, often because the body has started producing antibodies against the drug or because the drug level has drifted too low for other reasons.
The good news is that for patients who do achieve and maintain remission, the results can be durable. In one long-term follow-up study, 90% of UC patients who entered remission on Remicade maintained it throughout the monitoring period. Consistent dosing on schedule, without skipping or delaying infusions, helps maintain adequate drug levels and reduces the risk of antibody formation.
What to Expect During Induction
Each infusion itself takes about two hours, sometimes longer if your infusion center runs it slowly to watch for reactions. You’ll have three infusions over six weeks during induction. Many people describe feeling somewhat better after the first or second infusion, with more substantial improvement after the third. Some people feel fatigued or slightly off for a day or two after each infusion, which is normal.
If you’re tracking your progress, the most useful markers are stool frequency, the presence of blood, nighttime waking due to bowel symptoms, and overall energy levels. A gradual downward trend in these symptoms over the first six to eight weeks is a strong signal that the drug is working. If you see no change at all after two infusions, it’s worth discussing drug level testing with your gastroenterologist rather than waiting until the full 14-week window has passed.